Read + Share
Amedeo Smart
Independent Medical Education
Iacobucci G. Semaglutide: UK regulator approves drug for prevention of cardiovascular events. BMJ 2024;386:q1660.PMID: 39053933
Email
LinkedIn
Privacy Policy